Anebulo Pharmaceuticals
3 clinical trials · Sponsor
◉ Watch Anebulo Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| I.V. Selonabant in Healthy Adult Subjects (NCT07211607) | Anebulo Pharmaceuticals | 2025-09-22 |
| Observational Study of THC Concentrations in Acute Cannabis-induced CNS Depression (NCT06017622) | Anebulo Pharmaceuticals | 2023-06-01 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CB1 Antagonist ANEB-001 in a THC Challenge Test (NCT05282797) | Anebulo Pharmaceuticals | 2021-12-15 |
Track Anebulo Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.